Profile
Andreas Müller′s practice focuses on public and private mergers & acquisitions, private equity and capital markets. He also regularly advises on matters of corporate governance and executive compensation, as well as corporate law and securities regulation.
Sectors
Experience
Select Menu
Andreas Müller is an M&A, corporate, capital markets and executive compensation specialist. Andreas acts as advisor on buy- and sell-side public and private M&A transactions and to issuers and investors in equity and hybrid financing transactions. In addition, he advises boards, board committees and companies on complex corporate governance, securities law and executive compensation matters and activist defense. He also acts as advisor in corporate restructurings and general corporate and commercial matters.
He is admitted to practice in Switzerland and New York and recognized as an authorized issuer’s representative at the SIX Swiss Exchange. He has published numerous articles on corporate, securities and commercial law, corporate governance and executive compensation topics in Swiss and international commentaries and journals. He is an editor of one of Switzerland’s leading legal journals on corporate and capital markets law (Schweizerische Zeitschrift für Gesellschafts- und Kapitalmarktrecht, GesKR) and the editor of the leading commentary on Swiss executive compensation rules.
Experience highlights (prior to joining NKF) include advising:
M&A
- DALI Discount on the secondary investment by ALDI SÜD Group (2026)
- 908 Devices on its acquisition of NIRLAB (2026)
- AECOM on its acquisition of Norwegian AI company Consigli (2026)
- HWP Group on the acquisition of Global Market Access Solutions (2026)
- Element Solutions on its USD 500 m acquisition of Micromax from Celanese (2026)
- Clariness AG on the sale to SubjectWell, Inc. (2026)
- Windward Bio on its up to USD 700 m licensing deal with Qyuns (2025) and its licensing deal with Kelun-Biotech and Harbour BioMed (2025)
- Biocorp on SK Capital’s EUR 1.5 bn investment in Swixx BioPharma (2025)
- Marex Group plc on the acquisition of fixed-income market maker Valcourt SA (2025)
- ABB on the carve-out and USD 5.375 bn sale of its robotics division to SoftBank (2025) and on the separation of the Power Grids business and the completion of its USD 11 bn divestment to Hitachi (2020)
- Zurich Airport on its CHF 155 m purchase of the Radisson Blu Building at Zurich Airport (2025)
- UBS on the merger of Pillar 2-FZG and Pillar 3a pension foundations (2025)
- BIOTRONIK on sale of VI Business to Teleflex (2025)
- HR Group on its acquisition of H-Hotels (2025)
- Novo Nordisk / Novo Holdings on its USD 11 bn acquisition of Catalent (2025)
- Pollen Street Capital on its acquisition of Etops Group (2024)
- Lotus Bakeries on its strategic partnership with Mondelēz International (2024)
- Biocorp on its USD 220 m sale of Biopas to Swixx Biopharma (2024)
- Müller Martini on its acquisition of Hunkeler (2023)
- VectivBio with respect to the USD 1 bn public cash tender offer from Ironwood Pharmaceuticals (2023) and on its acquisition of Comet Therapeutics (2021)
- AEQUITA on its acquisition of Saint-Gobain’s Swiss Glassolutions Business (2023)
- Solenis on the USD 4.6 bn acquisition of Diversey (2023) and its acquisition of Kolb’s paper process chemicals business (2022)
- Credit Suisse on its merger with UBS (2023)
- Affective Advisory GmbH and the seller on joining forces with «Team Farner» (2023)
- Tiedemann Group on its business combination with Alvarium Investments and Cartesian Growth Corporation to form Nasdaq-listed AlTi (2023)
- AMF Medical and its shareholders on the CHF 200 bn sale of AMF Medical to Tandem Diabetes Care (2022)
- G. Capital on its acquisition of Celerion (2022)
- Avolta (formerly Dufry) on the USD 6.7 bn strategic combination with Autogrill (2022), its acquisition of all remaining equity interest in Hudson and the related equity financing (2020), its CHF 3.8 bn acquisition of World Duty Free (2015), its CHF 1.55 bn acquisition of The Nuance Group (2014), its USD 446 m acquisition of Hudson Group (2008) and its EUR 328 m acquisition of the remaining 49% of Hellenic Duty Free (2013)
- Ahlström Capital on the merger of Enics with GPV (2022)
- Azolver Holding on the sale of all its operative subsidiaries to Francotyp-Postalia (2022)
- Sonova on its acquisition of Sennheiser’s Consumer Division (2022)
- Metall Zug on the quasi-merger of its Business Unit Wire Processing with Komax (2022)
- Nitto on the sale of its specialized adhesive films technology for side curtain airbags to ZF (2022)
- ASML on the sale of Berliner Glas Medical and SwissOptic (2021) and its acquisition of Berliner Glas (2020)
- Platinum Equity in its USD 5.25 bn acquisition of Solenis (2021)
- Grünenthal on its acquisition of Mestex (2021)
- ARYZTA AG on the USD 850 mn disposal of its North American business to Lindsay Goldberg (2021)
- TPG Growth in its acquisition of People 2.0 (2021)
- Silversmith Capital Partners and Appfire Technologies on its acquisition of beecom Products (2020)
- Tiedemann Advisors and Constantia Partners on their joint venture Tiedemann Constantia (2019)
- Sale of Therachon with its Achondroplasia program to Pfizer (up to USD 810 m) and the spin-off of Therachon’s Apraglutide program (2019)
- Finatem IV on its acquisition of a majority stake in Mungo Befestigungstechnik (2018)
- Clariant on a MoU with SABIC regarding the combination of high performance materials businesses and on its entry into a governance agreement with SABIC regarding future governance principles of Clariant (2018), on the CHF 2.35 bn sale of activist shareholder White Tale’s 24.99% stake to SABIC (2018) and on its planned USD 20 bn cross-border merger with Huntsman Corporation (2017)
- Sulzer on the CHF 500 m acquisition of 5 m Sulzer shares from Renova (2018)
- and Dr. G. Abivardi on the sale of swiss smile and their reinvestment to Jacobs Holding (2017)
- Fairfax Financial on its USD 4.9 bn acquisition of Allied World Assurance Company Holdings, AG (2016)
- Boehringer Ingelheim on the USD 22.7 bn swap of its consumer healthcare business for Sanofi’s animal health business (2016)
- Generali on the CHF 1.25 bn sale of BSI to BTG Pactual (2015)
- Givaudan on its acquisition of Induchem (2015)
- Royal Bank of Scotland on the sale of Coutts International to Union Bancaire Privée (2015)
- Kaba on its CHF 4 bn cross-border merger with Dorma Group (2015)
- Holcim on its CHF 41 bn merger with Lafarge (2014 / 2015)
- Tyco International on its redomiciliation from Switzerland to Ireland (2014)
Investment and Equity-Based Financing Transactions
- Representing biotech, medtech and life science companies, including ADC Therapeutics, Alentis Therapeutics, AMF Medical, VectivBio, Windward Bio, as well as investors such as Baker Brothers, Novo Holdings and Hevolution Foundation
- Representing tech and AI companies, including Kandou AI and wefox, as well as investors such as General Catalyst and NVentures (NVIDIA)
- DALI DISCOUNT AG in connection with its financing rounds, including the Series D financing round by ALDI SÜD Group (2022-2026)
Capital Market Transactions
- Kühne + Nagel International on its long-term strategic collaboration with Amazon, including a call option structure (2026)
- Liberty Global and Sunrise on the spin-off and listing of Sunrise on the SIX and NASDAQ (2024)
- Galderma on its USD 12 bn IPO on SIX Swiss Exchange (2024)
- Luzerner Kantonalbank on its CHF 489 m rights offering (2023)
- Credit Suisse Group AG on its CHF 4 bn private placement and rights offering (2022)
- VectivBio on its IPO on Nasdaq (2021), its follow-on public offering and concurrent private placement (2022) and its USD 125 m underwritten offering and amendment to its financing agreement with Kreos Capital (2022)
- Dufry on its CHF 700 m rights offering with commitments from Advent International and Alibaba Group and its strategic joint venture with Alibaba Group (2020) and its placement of 5.5 m shares and CHF 350 m convertible bonds (2020)
- ADC Therapeutics SA on its IPO on NYSE (2020)
- Dufry on the USD 1.6 bn IPO of its subsidiary Hudson on NYSE (2018)
Executive Compensation
- Advised almost all top 50 Swiss listed companies as well as numerous other listed companies on compliance with Swiss executive compensation (“Minder”) rules
- Frequently advises on all legal aspects of hires and departures of top executives
- Regularly advises public and privately held companies on the design and implementation of their cash- and equity-based incentive plans
- Advisor to numerous Swiss boards and compensation committees
- Corporate M&A 2026: Switzerland by Frank Gerhard, Andreas Müller, Timo Hasler in: Chambers Global Practice Guides: Corporate M&A 2026; Chambers & Partners
- Private M&A 2026: Switzerland in: Lexology Panoramic: Private M&A 2026; Law Business Research Ltd., 16. September 2025
- Corporate Governance and Directors’ Duties in Switzerland: Overview 2025 in: Thomson Reuters Practical Law, 26. August 2025 Reproduced from Practical Law with the permission of the publishers. For further information, visit practicallaw.com
- Corporate M&A 2025: Switzerland in: Chambers Global Practice Guides: Corporate M&A 2025; Chambers & Partners, 20. Mai 2025
- Private M&A 2025: Switzerland in: Lexology Panoramic: Private M&A 2025; Law Business Research Ltd., 10. Oktober 2024
- Corporate M&A 2024: Switzerland in: Chambers Global Practice Guides: Corporate M&A 2024; Chambers & Partners, 22. Mai 2024
- Corporate governance and directors’ duties in Switzerland: Overview 2024 / 2025 in: Thomson Reuters Practical Law, 01. April 2024 Reproduced from Practical Law with the permission of the publishers. For further information, visit practicallaw.com
- Private M&A 2024: Switzerland in: Lexology. Getting the Deal Through: Private M&A 2024; Law Business Research Ltd., 25. September 2023
- Corporate M&A 2023: Switzerland in: Chambers Global Practice Guides: Corporate M&A 2023; Chambers & Partners, 20. April 2023
- Corporate governance and directors’ duties in Switzerland: overview 2022 / 2023 in: Practical Law Global Guide 2023; Thomson Reuters, 15. März 2023
- The Executive Remuneration Review: Switzerland 2022 in: The Executive Remuneration Review: Switzerland, 11th edition, S. 231 – 242; Hrsg. Michael Albano; Law Business Research Ltd., 07. November 2022
- Private M&A 2023: Switzerland in: Lexology. Getting the Deal Through: Private M&A 2023; Law Business Research Ltd., 10. Oktober 2022
- Public M&A 2022: Switzerland in: Lexology. Getting the Deal Through: Public M&A 2022; Law Business Research Ltd., 08. Juni 2022
- Corporate M&A 2022: Switzerland in: Chambers Global Practice Guides: Corporate M&A 2022; Chambers & Partners, 11. Mai 2022
- Chapter 15: Compensation Rules of Listed Swiss Corporations in: Swiss Corporation Law: A Primer for Legal Practitioners, ed. Homburger, Schulthess, 08. April 2022
- Chapter 7: Board of Directors in: Swiss Corporation Law: A Primer for Legal Practitioners, ed. Homburger, Schulthess, 08. April 2022
- The Executive Remuneration Review: Switzerland in: The Executive Remuneration Review: Switzerland, 10th edition, pp. 246 – 278; Hrsg. Michael Albano; Law Business Research Ltd, 18. November 2021
- Private M&A 2022: Switzerland in: Lexology. Getting the Deal Through: Private M&A 2022; Law Business Research Ltd., 19. Oktober 2021
- Revidierte Regularien zur Ad hoc-Publizität in: GesKR 2/2021, S. 149-162, 01. Juli 2021
- Public M&A 2021: Switzerland in: Lexology. Getting the Deal Through: Public M&A 2021; Law Business Research Ltd., 21. Juni 2021
- Corporate M&A 2021: Switzerland in: Chambers Global Practice Guides: Corporate M&A 2021; Chambers & Partners, 21. April 2021
- Neues Aktienrecht: Tour d’Horizon in: GesKR 3 | 2020, S. 323 ff., Dike Verlag, 16. Dezember 2020
- The Executive Remuneration Review: Switzerland in: The Executive Remuneration Review: Switzerland, 9. Edition, S. 248 – 258; Michael Albano and Janet Cooper (Hrsg.); Law Business Research Ltd., 07. Dezember 2020
- Private M&A 2020: Switzerland in: Getting the Deal Through: Private M&A 2020 ; Law Business Research Ltd., Lexology, 10. Juni 2020
- Corporate governance and directors’ duties in Switzerland: overview in: Practical Law Global Guide 2020; Thomson Reuters, 02. Juni 2020
- Public M&A 2020: Switzerland in: Lexology. Getting the Deal Through: Public M&A 2020; Law Business Research Ltd., 27. Mai 2020
- Basler Kommentar zu Art. 120–126 OR (Verrechnung) in: Basler Kommentar – Obligationenrecht I, 7. Aufl., Basel 2019, S. 859–891; Helbing Lichtenhahn Verlag, 20. Dezember 2019
- Corporate governance and directors’ duties in Switzerland: overview in: Practical Law Global Guide 2019; Thomson Reuters, 04. Oktober 2019
- Public M&A 2019: Switzerland in: Lexology. Getting the Deal Through: Public M&A 2019; Law Business Research Ltd., 24. Juni 2019
- Private M&A 2019: Switzerland in: Getting the Deal Through: Private M&A 2019 ; Law Business Research Ltd., Lexology, 06. November 2018
- Vorbemerkungen zu Art. 13 VegüV und Kommentar zu Art. 13 – 17 und 31 VegüV (Vergütungsbericht / Compensation Report) in: VegüV – Praxiskommentar zur Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (Commentary on the Ordinance Against Excessive Compensation in Public Corporations), 2. Aufl., Zürich 2018, pp. 259 – 381 und 683 – 687; Schulthess Verlag, 22. August 2018
- Kommentar zu Art. 20 – 21 und 28 VegüV (Unzulässige Vergütungen / Impermissible Compensation; Anpassung von altrechtlichen Arbeitsverträgen / Amendment of Employment Contracts “Under the Old Law”) in: VegüV – Praxiskommentar zur Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (Commentary on the Ordinance Against Excessive Compensation in PublicCorporations), 2. Aufl., Zürich 2018, pp. 492 – 579 und 669 – 678; Schulthess Verlag, 22. August 2018
- Kommentar zu Art. 18 – 19 und 31 VegüV (Abstimmung der Generalversammlung über die Vergütungen / Vote of the General Meeting on Compensation) in: VegüV – Praxiskommentar zur Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (Commentary on the Ordinance Against Excessive Compensation in Public Corporations), 2. Aufl., Zürich 2018, pp. 382 – 491 und 683 – 687; Schulthess Verlag, 22. August 2018
- Kommentar zu Art. 22, 23 und 32 VegüV (Stimm- und Offenlegungspflicht für Vorsorgeeinrichtungen / Voting Obligation and Disclosure Obligation for Pension Funds) in: VegüV – Praxiskommentar zur Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (Commentary on the Ordinance Against Excessive Compensation in PublicCorporations), 2. Aufl., Zürich 2018, pp. 580 – 610 und 688 – 689; Schulthess Verlag, 22. August 2018
- Kommentar zu Art. 2, 12 und 27 VegüV (Generalversammlung / General Meeting; Statutenbestimmungen / Provisions of the Articles of Association; Anpassung von Statuten und Reglementen / Amendment of the Articles of Association and Regulations) in: VegüV – Praxiskommentar zur Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (Commentary on the Ordinance Against Excessive Compensation in Public Corporations), 2. Aufl., Zürich 2018, pp. 36 – 54, 188 – 258 und 662 – 668; Schulthess Verlag, 22. August 2018
- Allgemeine Einleitung und Kommentar zu Art. 95 Abs. 3 BV in: VegüV – Praxiskommentar zur Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (Commentary on the Ordinance Against Excessive Compensation in Public Corporations), 2. Aufl., Zürich 2018, pp. 1 – 14; Schulthess Verlag, 22. August 2018
- Kommentar zu Art. 26 VegüV (Übergangsbestimmungen / Transitional Provisions) in: VegüV – Praxiskommentar zur Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (Commentary on the Ordinance Against Excessive Compensation in Public Corporations) (VegüV), 2. Auflage, Zürich 2018, pp. 654 – 661; Schulthess Verlag, 21. August 2018
- Public M&A 2018: Switzerland in: Getting the Deal Through: Public M&A 2018, pp. 211- 217; Law Business Research Ltd., Lexology, 10. Juni 2018
- Corporate governance and directors’ duties in Switzerland: overview in: Practical Law Global Guide 2017; Thomson Reuters, 15. Dezember 2017
- Aktienrechtsentwurf 2016: Verbesserungen, aber auch Schwachstellen in: GesKR 1/2017, 25 ff.; Dike Verlag AG, 30. März 2017
- Corporate governance and directors’ duties in Switzerland: overview in: Practical Law Global Guide 2016/17; Thomson Reuters, 14. Dezember 2016
- Corporate governance and directors’ duties in Switzerland: overview in: Practical Law Global Guide 2015/16 ; Thomson Reuters, 04. Dezember 2015
- VegüV – Business as Usual? in: GesKR 2/2015, pp. 206 – 224; Dike Verlag AG, 23. Februar 2015
- VegüV – Quo vadis? Umsetzung der Bestimmungen der Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften im Vorentwurf zur «grossen» Aktienrechtsrevision in: GesKR 1/2015, pp. 98 – 108 ; Dike Verlag AG, 26. Januar 2015
- Corporate governance and directors’ duties in Switzerland: overview in: Practical Law Multi-jurisdictional Guide 2014/15; Thomson Reuters, 05. Januar 2015
- Kommentar zu Art. 26 VegüV (Übergangsbestimmungen / Transitional Provisions) in: VegüV – Praxiskommentar zur Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (Commentary on the Ordinance Against Excessive Compensation in Public Corporations), Zürich 2014, pp. 467 – 473 ; Schulthess Verlag, 28. September 2014
- Kommentar zu Art. 22, 23 und 32 VegüV (Stimm- und Offenlegungspflicht für Vorsorgeeinrichtungen / Voting Obligation and Disclosure Obligation for Pension Funds) in: VegüV – Praxiskommentar zur Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (Commentary on the Ordinance Against Excessive Compensation in Public Corporations), Zürich 2014, pp. 412 – 434 und 497 – 498 ; Schulthess Verlag, 27. September 2014
- Kommentar zu Art. 2, 12 und 27 VegüV (Generalversammlung / General Meeting; Statutenbestimmungen / Provisions of the Articles of Association; Anpassung von Statuten und Reglementen / Amendment of the Articles of Association and Regulations) in: VegüV – Praxiskommentar zur Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (Commentary on the Ordinance Against Excessive Compensation in Public Corporations), Zürich 2014, pp. 28 – 44, 152 – 198 und 474 – 478 ; Schulthess Verlag, 24. September 2014
- Vorbemerkungen zu Art. 13 VegüV und Kommentar zu Art. 13 – 17 und 31 VegüV (Vergütungsbericht / Compensation Report) in: VegüV – Praxiskommentar zur Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (Commentary on the Ordinance Against Excessive Compensation in Public Corporations), Zürich 2014, pp. 199 – 281 und 492 – 496; Schulthess Verlag, 23. September 2014
- Kommentar zu Art. 20 – 21 und 28 VegüV (Unzulässige Vergütungen / Impermissible Compensation; Anpassung von altrechtlichen Arbeitsverträgen / Amendment of Employment Contracts “Under the Old Law”) in: VegüV – Praxiskommentar zur Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (Commentary on the Ordinance Against Excessive Compensation in Public Corporations), Zürich 2014, pp. 358 – 411 und 479 – 487; Schulthess Verlag, 22. September 2014
- Kommentar zu Art. 18 – 19 und 31 VegüV (Abstimmung der Generalversammlung über die Vergütungen / Vote of the General Meeting on Compensation) in: VegüV – Praxiskommentar zur Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (Commentary on the Ordinance Against Excessive Compensation in Public Corporations), Zürich 2014, pp. 282 – 357 und 492 – 496; Schulthess Verlag, 21. September 2014
- Allgemeine Einleitung und Kommentar zu Art. 95 Abs. 3 BV in: VegüV – Praxiskommentar zur Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (Commentary on the Ordinance Against Excessive Compensation in Public Corporations), Zürich 2014, pp. 1 – 12; Schulthess Verlag, 04. September 2014
- Corporate governance and directors’ duties in Switzerland: overview in: Practical Law Multi-jurisdictional Guide Corporate Governance and Directors› Duties 2013-14; Thomson Reuters, 05. März 2014
- Protecting the Integrity of a Written Agreement in: The Hague 2013; Eleven international publishing, 24. September 2013
- Entwurf einer Verordnung zur Umsetzung von Artikel 95 Absatz 3 BV (Minder-Initiative) in: GesKR Online-Beitrag 2/2013, pp. 1 – 16; 24. April 2013
2013
PhD in Law (Dr. iur.), University of Basel
2013
Admitted to the New York Bar
2012
Harvard Law School (LL.M.)
2010
Admitted to the Swiss Bar (Attorney-at-law)
2008
University of Basel (lic. iur.)
Chambers Global 2026
Chambers Europe 2026
Legal500 EMEA 2026: Leading Partner
Legal500 EMEA 2026: Next Generation Partner
IFLR1000 2026: Rising Star Partner
Lexology Index – Switzerland 2026
Lexology Index – Thought Leaders: M&A and Governance 2026
Lexology Index – Thought Leaders: Switzerland 2026
Lexology Index – Capital Markets 2026
Lexology Index – M&A and Governance 2026
Legal500 EMEA 2024: Next Generation Partner
IFLR1000 2024 – Rising Star Partner
Lexology Index – Thought Leaders: M&A and Governance 2024
Swiss Bar Association
Zurich Bar Association
IBA International Bar Association
2026
Partner, Niederer Kraft Frey
2020
Partner at Homburger AG
2016
Associate, Freshfields Bruckhaus Deringer LLP, London
2013
Associate at Homburger AG
2009
Law clerk, District Court of Arlesheim
2008
Junior Associate at a major Swiss law firm
German
English
French